Know Cancer

or
forgot password
  • cancer clinical trials in kalispell, MT

  • Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Glacier Oncology, PLLC

    Trial Locations
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Breast Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Breast Cancer, Metastatic Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Glacier Oncology, PLLC

    Trial Locations
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Lung Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Bladder Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Glacier Oncology, PLLC

    Trial Locations
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Leukemia
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Brain and Central Nervous System Tumors
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma